Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 20 de 1.991
3.
Regul Toxicol Pharmacol ; 140: 105383, 2023 May.
Article En | MEDLINE | ID: mdl-36933643

BACKGROUND: Seven national medicines regulatory authorities in the East African Community (EAC) have embraced regulatory reliance, harmonization and work sharing through the EAC Medicines Regulatory Harmonization programme. Measuring the performance of regulatory systems provides key baseline information to build on regulatory system-strengthening strategies. Therefore, the aim of the study was to evaluate the regulatory performance of the EAC joint scientific assessment of applications approved between 2018 and 2021. METHODS: Utilising a data metrics tool, information was collected reflecting timelines for various milestones including submission to screening, scientific assessment and communication of regional recommendations for biologicals and pharmaceuticals that received a positive regional recommendation for product registration from 2018 to 2021. RESULTS: Several challenges as well as possible solutions were identified, including median overall approval times exceeding the EAC 465-day target and median times to issue marketing authorisation following EAC joint assessment recommendation that far exceeded the 116-day target. Recommendations included establishment of an integrated information management system and automation of the capture of regulatory timelines through the EAC metric tool. CONCLUSIONS: Despite initiative progress, work is required to improve the EAC joint regulatory procedure to achieve regulatory systems-strengthening and ensure patients' timely access to safe, efficacious and quality medicines.


Drug Approval , Government Agencies , Government Regulation , State Medicine , State Medicine/legislation & jurisprudence , Africa, Eastern , Drug Approval/legislation & jurisprudence , Government Agencies/legislation & jurisprudence , Federal Government
11.
Br J Nurs ; 30(15): 936-937, 2021 Aug 12.
Article En | MEDLINE | ID: mdl-34379476

John Tingle, Lecturer in Law, Birmingham Law School, University of Birmingham, discusses the NHS Resolution annual report and accounts for 2020/21 and recent advice from the Medical Defence Union.


State Medicine , Humans , State Medicine/legislation & jurisprudence , United Kingdom
12.
Ann R Coll Surg Engl ; 103(8): 548-552, 2021 Sep.
Article En | MEDLINE | ID: mdl-34464556

INTRODUCTION: Medical malpractice litigation is a major concern for all spine surgeons. Our aim was to evaluate the incidence and burden of successful litigation relating to the management of spinal disorders over 12 years within a UK NHS tertiary-level spinal unit and compare these litigation costs with those of other specialties. METHODS: We obtained all data held by our claims department from its inception in January 2008 to December 2019. We also obtained costs for the total financial burden incurred by our Trust during this period. RESULTS: In total, there were 83 closed claims involving spinal pathologies. Over 80% of these comprised negligent surgery (n = 28, 34%), delay to diagnose/treat (n = 25, 30%) and negligent care (n = 18, 22%). The vast majority of claims were withdrawn without incurring any cost to the hospital (n = 59, 71%) and only 24 (29%) resulted in successful litigation for the claimant. The total cost of damages for these 24 successful claims was just over £8 million, including legal costs of £2.5 million, out of total litigation costs of £381 million over this period. DISCUSSION: Fewer than 30% of initial claims against a tertiary spinal surgical referral unit resulted in a successful financial outcome for the claimant. The total costs incurred were just over £8 million, with one-third apportioned to high legal costs, reflecting the complexity of resolving spinal litigation. Our entire legal expenses accounted for only 2% of the total legal bill paid by our hospital over a 12-year period.


Malpractice/economics , Neurosurgical Procedures/legislation & jurisprudence , Spinal Diseases/surgery , Humans , Malpractice/legislation & jurisprudence , State Medicine/economics , State Medicine/legislation & jurisprudence , United Kingdom
13.
Ann R Coll Surg Engl ; 103(8): 546-547, 2021 Sep.
Article En | MEDLINE | ID: mdl-34464564

INTRODUCTION: The aim of this study was to identify the causes of urological litigation in the NHS and to make recommendations how to reduce the burden of litigation to both injured patients and urologists. METHODS: Under the Freedom of Information Act, the National Health Service Resolution (NHSR) was asked to provide the figures for the number of cases of litigation in urology reported between 2010 and 2020. RESULTS: The number of urological claims more than doubled between 2011 and 2020. Many of the claims that are made result from avoidable errors. CONCLUSION: More education is needed, of both urologists in training and consultant urologists, on the causes of errors that lead to litigation and how many of them can be avoided.


Malpractice/statistics & numerical data , Urology , Humans , Malpractice/legislation & jurisprudence , State Medicine/legislation & jurisprudence , United Kingdom
15.
Br J Nurs ; 30(14): 870-871, 2021 Jul 22.
Article En | MEDLINE | ID: mdl-34288754

John Tingle, Lecturer in Law, Birmingham Law School, University of Birmingham, discusses some recent reports on artificial intelligence (AI) and machine learning in the context of law, ethics and patient safety.


Artificial Intelligence , Patient Safety , State Medicine , Computers , Humans , State Medicine/ethics , State Medicine/legislation & jurisprudence , United Kingdom
18.
Med Law Rev ; 29(3): 547-561, 2021 Oct 08.
Article En | MEDLINE | ID: mdl-34160040

In Chester v Afshar [2004], the House of Lords stated they were departing from the traditional rules of causation in order to vindicate the patient's right of autonomy. Subsequent judgments in the Court of Appeal expressed concerns over the lack of clarity of the legal principles to be derived from that judgment. In Correia v University Hospital of North Staffordshire NHS Trust [2017] and Diamond v Royal Devon and Exeter NHS Foundation Trust [2019], however, the Court of Appeal sought to clarify the scope and limits of Chester. This commentary sets out the scope and limits of Chester in light of those judgments and considers the extent to which they can be said to be vindicating patient autonomy. Drawing upon Coggon's typology of autonomy, it concludes that future judgments should utilise that typology to explicate which understanding of autonomy they are seeking to protect.


Decision Making , Disclosure/legislation & jurisprudence , Malpractice/legislation & jurisprudence , Personal Autonomy , Causality , Liability, Legal , State Medicine/legislation & jurisprudence , United Kingdom
20.
BJU Int ; 128(3): 361-365, 2021 09.
Article En | MEDLINE | ID: mdl-33773003

OBJECTIVE: To look into the urology litigation trends and successful claims in the National Health Service (NHS) over the last 20 years. METHODS: We requested data from NHS Resolutions to investigate current litigation numbers, costs and causes for claims. Data collected included the number of claims dating from 1996 to 2019, the total sum of damages paid out each year for urology and the causes for the claims dating from 2009 to 2019. Data from NHS Resolutions were analysed, stratified and categorized by the authors from this information, which was provided as two separate documents. RESULTS: The total cost of damages between 1997 and 2017 was £74.5m (range: £241 325-£7.8m per year). While the number of successful claims was 1653 (range 7-168 per year), the total number of claims was 3341 (range 31-347 per year) and, over time, this has increased almost sevenfold. The cost of damages has increased roughly in line with the number of claims. Over the last 10 years, non-operative-related claims accounted for 984 claims, of which the largest subset was for 'the failure to diagnose and/or treat' (n = 639, 65%), with 88 (9%) successful consent-related claims. There were 226 intra-operative-related claims. Of these, wrong-site surgery, a never-event, accounted for eight claims and there were six successful claims for failing to supervise juniors. A total of 1129 claims were postoperative claims, with retained foreign body or instrument accounting for 71 (6%) of these. CONCLUSIONS: The number and cost of litigation claims have increased year on year. There is a need for continual improvement in patient care, surgical training, counselling, informed consent and early management of complications. The evidence reviewed in this paper suggests that the best approach to this is the combination of rigid adherence to and re-enforcement of common surgical guidelines and implementation of the national 'Getting it right first time' initiative.


Malpractice/economics , Malpractice/legislation & jurisprudence , State Medicine/legislation & jurisprudence , Urology/economics , Urology/legislation & jurisprudence , Humans , Time Factors , United Kingdom
...